Zoryve Cream
Product Images NDC 80610-130

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoryve (NDC 80610-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arcutis Biotherapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Roflumilast 01)

FDA Label Image

Figure 1 (Roflumilast 02)

FDA Label Image

Principal Display Panel (60 g Tube Carton)

Principal Display Panel (60 g Tube Carton)
ZORYVE is a cream used for topical application only. It contains 0.3% roflumilast and is not intended for oral, ophthalmic, or intravaginal use. The cream should be kept out of children's reach, and each gram of the cream contains ceteareth 10 phospha, cetostearyl alcohol diethylene glycol monoisinyl ether, hexylene glycol, propylparaben, and white petrolatum. The recommended dosage should be seen in the prescription information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.